Dipartimento di Scienze Mediche e di Comunità, Università degli Studi di Milano, Milano, Italy.
Health Qual Life Outcomes. 2012 Nov 23;10:139. doi: 10.1186/1477-7525-10-139.
Chronic allograft nephropathy (CAN) occurs in a large share of transplant recipients and it is the leading cause of graft loss despite the introduction of new and effective immunosuppressants. The reduction in renal function secondary to immunologic and non-immunologic CAN leads to several complications, including anemia and calcium-phosphorus metabolism imbalance and may be associated to worsening Health-Related Quality of Life. We sought to evaluate the relationship between kidney function and Euro-Qol 5 Dimension Index (EQ-5Dindex) scores after kidney transplantation and evaluate whether cross-cultural differences exist between UK and US.
This study is a secondary analysis of existing data gathered from two cross-sectional studies. We enrolled 233 and 209 subjects aged 18-74 years who received a kidney transplant in US and UK respectively. For the present analysis we excluded recipients with multiple or multi-organ transplantation, creatinine kinase ≥200 U/L, acute renal failure, and without creatinine assessments in 3 months pre-enrollment leaving 281 subjects overall. The questionnaires were administered independently in the two centers. Both packets included the EQ-5Dindex and socio-demographic items. We augmented the analytical dataset with information abstracted from clinical charts and administrative records including selected comorbidities and biochemistry test results. We used ordinary least squares and quantile regression adjusted for socio-demographic and clinical characteristics to assess the association between EQ-5Dindex and severity of chronic kidney disease (CKD).
CKD severity was negatively associated with EQ-5Dindex in both samples (UK: ρ= -0.20, p=0.02; US: ρ= -0.21, p=0.02). The mean adjusted disutility associated to CKD stage 5 compared to CKD stage 1-2 was Δ= -0.38 in the UK sample, Δ= -0.11 in the US sample and Δ= -0.22 in the whole sample. The adjusted median disutility associated to CKD stage 5 compared to CKD stage 1-2 for the whole sample was 0.18 (p<0.01, quantile regression). Center effect was not statistically significant.
Impaired renal function is associated with reduced health-related quality of life independent of possible confounders, center-effect and analytic framework.
慢性移植肾肾病(CAN)在很大比例的移植受者中发生,尽管新的和有效的免疫抑制剂已经问世,但它仍然是移植物丢失的主要原因。免疫和非免疫性 CAN 导致的肾功能下降会引发多种并发症,包括贫血和钙磷代谢失衡,并可能导致健康相关生活质量恶化。我们旨在评估肾移植后肾功能与欧洲五维健康量表指数(EQ-5Dindex)评分之间的关系,并评估英国和美国之间是否存在文化差异。
这是对两项横断面研究中现有数据进行的二次分析。我们分别纳入了年龄在 18-74 岁之间在美国和英国接受肾移植的 233 名和 209 名受试者。对于本次分析,我们排除了接受过多次或多器官移植、肌酸激酶≥200U/L、急性肾衰竭且在入组前 3 个月内未进行肌酐评估的受者,最终纳入 281 名受试者。两个中心分别独立进行问卷调查。两个数据包均包括 EQ-5Dindex 和社会人口统计学项目。我们从临床图表和行政记录中提取了信息来补充分析数据集,包括选定的合并症和生化检测结果。我们使用普通最小二乘法和分位数回归,根据社会人口统计学和临床特征调整,评估 EQ-5Dindex 与慢性肾脏病(CKD)严重程度之间的关联。
在两个样本中,CKD 严重程度与 EQ-5Dindex 呈负相关(英国:ρ=-0.20,p=0.02;美国:ρ=-0.21,p=0.02)。与 CKD 1-2 期相比,CKD 5 期的平均调整后的不良效用差为英国样本为Δ=-0.38,美国样本为Δ=-0.11,总样本为Δ=-0.22。总样本中,与 CKD 1-2 期相比,CKD 5 期的调整后中位数不良效用差为 0.18(p<0.01,分位数回归)。中心效应无统计学意义。
肾功能受损与健康相关生活质量下降相关,独立于可能的混杂因素、中心效应和分析框架。